It acts as a vital negative regulator of the type I interferon (IFN) (28) and nuclear factor kappa-B (NF-κB) (29) signaling pathways, inhibits the generation of inflammatory cytokines, and regulates the response to viral infections. This evidence concerns the gene IFNA1 and viral infectious disease.